These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 32378631

  • 1. [Alcohol dependence and opioid receptor -Pharmacological profile of nalmefene].
    Ohgi Y.
    Nihon Yakurigaku Zasshi; 2020; 155(3):145-148. PubMed ID: 32378631
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological profile and clinical findings of nalmefene (Selincro®) for reducing alcohol consumption in patients with alcohol dependence].
    Tadori Y.
    Nihon Yakurigaku Zasshi; 2020; 155(2):113-119. PubMed ID: 32115477
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM, Koob GF.
    Neuropsychopharmacology; 2008 Feb; 33(3):643-52. PubMed ID: 17473837
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
    Kato H.
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
    [Abstract] [Full Text] [Related]

  • 5. Nalmefene for the treatment of alcohol dependence: a current update.
    Soyka M.
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):675-84. PubMed ID: 24246244
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distinct Effects of Nalmefene on Dopamine Uptake Rates and Kappa Opioid Receptor Activity in the Nucleus Accumbens Following Chronic Intermittent Ethanol Exposure.
    Rose JH, Karkhanis AN, Steiniger-Brach B, Jones SR.
    Int J Mol Sci; 2016 Jul 27; 17(8):. PubMed ID: 27472317
    [Abstract] [Full Text] [Related]

  • 13. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity?
    Bart G, Schluger JH, Borg L, Ho A, Bidlack JM, Kreek MJ.
    Neuropsychopharmacology; 2005 Dec 27; 30(12):2254-62. PubMed ID: 15988468
    [Abstract] [Full Text] [Related]

  • 14. Endogenous opioid systems and alcohol addiction.
    Herz A.
    Psychopharmacology (Berl); 1997 Jan 27; 129(2):99-111. PubMed ID: 9040115
    [Abstract] [Full Text] [Related]

  • 15. Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.
    Soyka M, Rösner S.
    Curr Drug Abuse Rev; 2008 Nov 27; 1(3):280-91. PubMed ID: 19630726
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Opioid modulators for alcohol dependence.
    Hillemacher T, Heberlein A, Muschler MA, Bleich S, Frieling H.
    Expert Opin Investig Drugs; 2011 Aug 27; 20(8):1073-86. PubMed ID: 21651459
    [Abstract] [Full Text] [Related]

  • 19. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun 27; 23(150):150-2. PubMed ID: 25121147
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.